Cardiovascular Disease | Alnylam® Newsroom

Global English
- Austria Deutsch
- Belgium Nederlands Français
- Brazil Português
- Canada Français English
- Denmark Dansk
- France Français
- Germany Deutsch
- Ireland English
- Italy Italiano
- Japan 日本語
- Luxembourg Français Deutsch
- Netherlands Nederlands
- Portugal Português
- Spain Español
- Sweden Svenska
- Switzerland Français Deutsch Italiano
- Taiwan 繁體中文
- United Kingdom English

Cardiovascular Disease

September 26, 2024 Confronting the World’s Leading Killer with a New Therapeutic Approach For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure. Read More ›

Subscribe to Cardiovascular Disease

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site